Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vascular Surgery

Free Subscription Articles published in Heart Retrieve available abstracts of 86 articles: HTML format Text format

Single Articles

March 2019
1. ANDERSON RH
   Hypoplastic left heart syndrome: the importance of phenotypic diagnosis.
   Heart. 2019;105:499.
   PubMed     Text format    
   
   
   December 2018
2. FEINBERG J, Nielsen EE, Gluud C, Jakobsen JC, et al
   Cochrane Corner: drug-eluting stents versus bare-metal stents for acute coronary syndrome.
   Heart. 2018;104:1895-1897.
   PubMed     Text format    
   
   
   
3. CAPODANNO D
   Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update.
   Heart. 2018;104:1976-1983.
   PubMed     Text format    
   
   
   November 2018
4. HUANG HD, Lombardi WL, Steinberg ZL
   Young man presenting with out-of-hospital cardiac arrest.
   Heart. 2018;104:1771-1802.
   PubMed     Text format     Abstract available
   
   
   
5. HEUTS S, Adriaans BP, Gerretsen S, Natour E, et al
   Aortic elongation part II: the risk of acute type A aortic dissection.
   Heart. 2018;104:1778-1782.
   PubMed     Text format     Abstract available
   
   
   October 2018
6. TESTORI C, Beitzke D, Mangold A, Sterz F, et al
   Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial.
   Heart. 2018 Oct 25. pii: heartjnl-2018-313705. doi: 10.1136/heartjnl-2018-313705
   PubMed     Text format     Abstract available
   
   
   
7. OTTO CM
   Heartbeat: improving outcomes after myocardial infarction.
   Heart. 2018;104:1553-1554.
   PubMed     Text format    
   
   
   September 2018
8. AL-LAMEE RK, Nowbar AN, Francis DP
   Percutaneous coronary intervention for stable coronary artery disease.
   Heart. 2018 Sep 21. pii: heartjnl-2017-312755. doi: 10.1136/heartjnl-2017-312755
   PubMed     Text format     Abstract available
   
   
   
9. OTTO CM
   Heartbeat: The ongoing controversy of intervention for chronic total coronary occlusions.
   Heart. 2018;104:1385-1387.
   PubMed     Text format    
   
   
   
10. SCHWARTZ I, McCracken CE, Petit CJ, Sachdeva R, et al
    Late outcomes after the Fontan procedure in patients with single ventricle: a meta-analysis.
    Heart. 2018;104:1508-1514.
    PubMed     Text format     Abstract available
    
    
    
11. GALAPPATTHY P, Bataduwaarachchi VR, Ranasinghe P, Galappatthy GKS, et al
    Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka.
    Heart. 2018;104:1424-1431.
    PubMed     Text format     Abstract available
    
    
    June 2018
12. FAHEY JK, Ihdayhid AR, White AJ
    A 42-year-old woman with acute myocardial infarction.
    Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779
    PubMed     Text format    
    
    
    
13. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    
    
    
    May 2018
14. KANDAN SR, Johnson TW
    Management of percutaneous coronary intervention complications.
    Heart. 2018 May 14. pii: heartjnl-2017-311155. doi: 10.1136/heartjnl-2017-311155
    PubMed     Text format    
    
    
    
15. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    PubMed     Text format     Abstract available
    
    
    April 2018
16. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
    PubMed     Text format    
    
    
    
17. JENKINS D
    New interventions to treat chronic thromboembolic pulmonary hypertension.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312110. doi: 10.1136/heartjnl-2017-312110
    PubMed     Text format     Abstract available
    
    
    
18. AVITABILE CM, Goldberg DJ, Leonard MB, Wei ZA, et al
    Leg lean mass correlates with exercise systemic output in young Fontan patients.
    Heart. 2018;104:680-684.
    PubMed     Text format     Abstract available
    
    
    March 2018
19. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
    PubMed     Text format    
    
    
    
20. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Text format     Abstract available
    
    
    
21. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    
    
    
    
22. CAULDWELL M, Steer PJ, Bonner S, Asghar O, et al
    Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair.
    Heart. 2018;104:401-406.
    PubMed     Text format     Abstract available
    
    
    
23. DE BELDER AJ
    Rotational atherectomy: re-emergence of an old technique.
    Heart. 2018;104:440-448.
    PubMed     Text format    
    
    
    
24. STOJKOVIC S, Milasinovic D
    Chronic total occlusion percutaneous coronary intervention in clinical practice: novel grounds to be EXPLOREd.
    Heart. 2018 Mar 1. pii: heartjnl-2018-312940. doi: 10.1136/heartjnl-2018-312940.
    PubMed     Text format    
    
    
    February 2018
25. GARCIA-ARRIBAS D, Vilacosta I, Ortega Candil A, Rodriguez Rey C, et al
    Usefulness of positron emission tomography/computed tomography in patients with valve-tube graft infection.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312918. doi: 10.1136/heartjnl-2017-312918
    PubMed     Text format     Abstract available
    
    
    
26. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Text format     Abstract available
    
    
    
27. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    PubMed     Text format    
    
    
    
28. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Text format     Abstract available
    
    
    
29. GAASCH WH, Meyer TE
    Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312002. doi: 10.1136/heartjnl-2017-312002.
    PubMed     Text format     Abstract available
    
    
    
30. OLIER I, Sirker A, Hildick-Smith DJR, Kinnaird T, et al
    Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312366. doi: 10.1136/heartjnl-2017-312366.
    PubMed     Text format     Abstract available
    
    
    
31. HAYS BS, Baker M, Laib A, Tan W, et al
    Histopathological abnormalities in the central arteries and veins of Fontan subjects.
    Heart. 2018;104:324-331.
    PubMed     Text format     Abstract available
    
    
    
32. AVERIN K, Byrnes JW, Benscoter DT, Whiteside W, et al
    Life-threatening airway bleeding after palliation of single ventricle congenital heart disease.
    Heart. 2018;104:254-260.
    PubMed     Text format     Abstract available
    
    
    
33. LATUS H, Nassar MS, Wong J, Hachmann P, et al
    Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome.
    Heart. 2018;104:244-252.
    PubMed     Text format     Abstract available
    
    
    January 2018
34. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627
    PubMed     Text format    
    
    
    
35. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Text format     Abstract available
    
    
    
36. SMILOWITZ NR, Gupta N, Guo Y, Beckman JA, et al
    Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.
    Heart. 2018 Jan 5. pii: heartjnl-2017-312391. doi: 10.1136/heartjnl-2017-312391.
    PubMed     Text format     Abstract available
    
    
    
37. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
    Myocardial revascularisation in high-risk subjects.
    Heart. 2018;104:166-179.
    PubMed     Text format    
    
    
    
38. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2018;104:90-92.
    PubMed     Text format    
    
    
    
39. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2018;104:127-134.
    PubMed     Text format     Abstract available
    
    
    December 2017
40. QUANDT D, Ramchandani B, Penford G, Stickley J, et al
    Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot.
    Heart. 2017;103:1985-1991.
    PubMed     Text format     Abstract available
    
    
    
41. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available
    
    
    
42. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    
    
    
    November 2017
43. TOYOTA T, Morimoto T, Shiomi H, Yamaji K, et al
    Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
    Heart. 2017 Nov 16. pii: heartjnl-2017-312117. doi: 10.1136/heartjnl-2017-312117
    PubMed     Text format     Abstract available
    
    
    
44. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available
    
    
    
45. TANG E, Wei ZA, Whitehead KK, Khiabani RH, et al
    Effect of Fontan geometry on exercise haemodynamics and its potential implications.
    Heart. 2017;103:1806-1812.
    PubMed     Text format     Abstract available
    
    
    
46. EGBE AC, Khan AR, Ammash NM, Barbara DW, et al
    Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.
    Heart. 2017;103:1813-1820.
    PubMed     Text format     Abstract available
    
    
    
47. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Text format     Abstract available
    
    
    
48. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Text format     Abstract available
    
    
    October 2017
49. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    PubMed     Text format    
    
    
    
50. WANG N, Fulcher J, Abeysuriya N, Adams M, et al
    Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis.
    Heart. 2017 Oct 6. pii: heartjnl-2017-311986. doi: 10.1136/heartjnl-2017-311986.
    PubMed     Text format     Abstract available
    
    
    
51. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available
    
    
    September 2017
52. PICCOLO R, Franzone A, Windecker S
    From bare metal to barely anything: an update on coronary stenting.
    Heart. 2017 Sep 19. pii: heartjnl-2016-310877. doi: 10.1136/heartjnl-2016-310877
    PubMed     Text format    
    
    
    
53. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Text format     Abstract available
    
    
    
54. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Text format     Abstract available
    
    
    August 2017
55. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Text format     Abstract available
    
    
    July 2017
56. KURLANSKY PA
    Arterial grafting for coronary revascularisation and the illusive search for truth.
    Heart. 2017 Jul 12. pii: heartjnl-2017-311289. doi: 10.1136/heartjnl-2017-311289
    PubMed     Text format    
    
    
    
57. UDINK TEN CATE FEA, Trieschmann U, Germund I, Hannes T, et al
    Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits.
    Heart. 2017;103:1111-1116.
    PubMed     Text format     Abstract available
    
    
    
58. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Text format     Abstract available
    
    
    
59. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    
    
    
    June 2017
60. COCKBURN J, Hildick-Smith DJ, Trivedi U, de Belder AJ, et al
    Re: A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    
    
    
    
61. BLAKE SR
    A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    
    
    
    April 2017
62. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Text format     Abstract available
    
    
    
63. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    
    
    
    March 2017
64. OPOTOWSKY AR, Baraona FR, Mc Causland FR, Loukas B, et al
    Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Heart. 2017;103:434-442.
    PubMed     Text format     Abstract available
    
    
    
65. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available
    
    
    
66. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Text format     Abstract available
    
    
    
67. HARBRON RW, Chapple CL, O'Sullivan JJ, Best KE, et al
    Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children.
    Heart. 2017;103:341-346.
    PubMed     Text format     Abstract available
    
    
    February 2017
68. KIM YY, Rathod RH, Gauvreau K, Keenan EM, et al
    Factors associated with severe aortic dilation in patients with Fontan palliation.
    Heart. 2017;103:280-286.
    PubMed     Text format     Abstract available
    
    
    
69. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available
    
    
    January 2017
70. ALSAIED T, Bokma JP, Engel ME, Kuijpers JM, et al
    Factors associated with long-term mortality after Fontan procedures: a systematic review.
    Heart. 2017;103:104-110.
    PubMed     Text format     Abstract available
    
    
    
71. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available
    
    
    
72. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available
    
    
    
73. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    
    
    
    December 2016
74. KIM NH, D'Armini AM, Grimminger F, Grunig E, et al
    Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Heart. 2016 Dec 23. pii: heartjnl-2016-309621. doi: 10.1136/heartjnl-2016-309621
    PubMed     Text format     Abstract available
    
    
    
75. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    
    
    
    November 2016
76. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    PubMed     Text format    
    
    
    September 2016
77. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    PubMed     Text format     Abstract available
    
    
    August 2016
78. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    PubMed     Text format    
    
    
    
79. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    PubMed     Text format    
    
    
    
80. MCWILLIAMS E, Zehr K, Alshehri A
    An unusual shadow above the aortic valve.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309932. doi: 10.1136/heartjnl-2016-309932
    PubMed     Text format     Abstract available
    
    
    
81. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Text format     Abstract available
    
    
    July 2016
82. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Text format     Abstract available
    
    
    
83. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Text format     Abstract available
    
    
    June 2016
84. SIZAROV A, Raimondi F, Bonnet D, Boudjemline Y, et al
    Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309352. doi: 10.1136/heartjnl-2016-309352
    PubMed     Text format     Abstract available
    
    
    May 2016
85. FUKUI S, Ogo T, Takaki H, Ueda J, et al
    Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Heart. 2016 May 24. pii: heartjnl-2015-309230. doi: 10.1136/heartjnl-2015-309230
    PubMed     Text format     Abstract available
    
    
    March 2016
86. SHI WY, Yong MS, McGiffin DC, Jain P, et al
    Heart transplantation in Fontan patients across Australia and New Zealand.
    Heart. 2016 Mar 21. pii: heartjnl-2015-308848. doi: 10.1136/heartjnl-2015-308848
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: